Transcription factor NKX2–1 drives serine and glycine synthesis addiction in cancer
2023 · British Journal of Cancer · 33 citations
https://doi.org/10.1038/s41416-023-02216-y
E
Elien Heylen
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
13
Papers
360
Citations
4
h-index
4
i10-index
Elien Heylen is an academic researcher from VIB-KU Leuven Center for Cancer Biology. The author has contributed to research in topics: Cancer, Hypoxia, and Metabolism & Amino Acid Enzymes and Metabolism & Chemical Synthesis and Analysis. The author has an h-index of 4, co-authored 12 publications.
ORCID: 0000-0002-8102-3209Papers by this author
worksTargeting serine/glycine metabolism improves radiotherapy response in non-small cell lung cancer
2023 · British Journal of Cancer · 19 citations
https://doi.org/10.1038/s41416-023-02553-y
1866: Targeting serine/glycine metabolism improves radiotherapy response in Non-Small Cell Lung Cancer
2024 · Radiotherapy and Oncology · 0 citations
https://doi.org/10.1016/s0167-8140(24)02182-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat